Scholars Central

Short communicationPublished 2017

Potential Involvement of the ILC2-Regulatory T Cell - Amphiregulin Axisin Liver Cancer Development: Novel Concepts for Immunotherapy of Hepatocellular Carcinoma

Authors: Katrin Neumann, Aaron Ochel, Gisa Tiegs

Journal of Clinical and Cellular Immunology

Volume 8 · Issue 5 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hepatocellular carcinoma (HCC) is the most common primary liver tumor and its incidence is increasing. Since this type of cancer is largely resistant to systemic therapies, there is urgent need to identify cellular and molecular pathways involved in the pathogenesis of HCC. Recent evidence implicates inflammation-induced, immune cell-derived amphiregulin (AREG) about interactions between immune cells of the innate and adaptive immune system by AREG in HCC development. We postulate an immunological network with pro-tumorigenic activity comprising AREG, type 2 innate lymphoid cells and regulatory T cells that might constitute a promising target for novel cancer immunotherapies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Katrin Neumann”
  • BylineArticles whose byline prints “Aaron Ochel”
  • BylineArticles whose byline prints “Gisa Tiegs”